Skip NavigationSkip to Content

Molecular mechanisms by which HERV-K Gag interferes with HIV-1 Gag assembly and particle infectivity.

  1. Author:
    Monde, Kazuaki [ORCID]
    Terasawa, Hiromi
    Nakano, Yusuke
    Soheilian, Ferri
    Nagashima, Kunio
    Maeda, Yosuke
    Ono, Akira
  2. Author Address

    Department of Medical Virology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan. monde@kumamoto-u.ac.jp., Department of Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan. monde@kumamoto-u.ac.jp., Laboratory of Viral Pathogenesis, Institute for Virus Research, Kyoto University, Kyoto, Japan., Electron Microscopy Laboratory, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA.,
    1. Year: 2017
    2. Date: Apr 26
    3. Epub Date: 2017 Apr 26
  1. Journal: Retrovirology
    1. 14
    2. 1
    3. Pages: 27
  2. Type of Article: Article
  3. Article Number: 27
  4. ISSN: 1742-4690
  1. Abstract:

    Human endogenous retroviruses (HERVs), the remnants of ancient retroviral infections, constitute approximately 8% of human genomic DNA. Since HERV-K Gag expression is induced by HIV-1 Tat in T cells, induced HERV-K proteins could affect HIV-1 replication. Indeed, previously we showed that HERV-K Gag and HIV-1 Gag coassemble and that this appears to correlate with the effect of HERV-K Gag expression on HIV-1 particle release and its infectivity. We further showed that coassembly requires both MA and NC domains, which presumably serve as scaffolding for Gag via their abilities to bind membrane and RNA, respectively. Notably, however, despite possessing these abilities, MLV Gag failed to coassemble with HIV-1 Gag and did not affect assembly and infectivity of HIV-1 particles. It is unclear how the specificity of coassembly is determined. Here, we showed that coexpression of HERV-K Gag with HIV-1 Gag changed size and morphology of progeny HIV-1 particles and severely diminished infectivity of such progeny viruses. We further compared HERV-K-MLV chimeric constructs to identify molecular determinants for coassembly specificity and for inhibition of HIV-1 release efficiency and infectivity. We found that the CA N-terminal domain (NTD) of HERV-K Gag is important for the reduction of the HIV-1 release efficiency, whereas both CA-NTD and major homology region of HERV-K Gag contribute to colocalization with HIV-1 Gag. Interestingly, these regions of HERV-K Gag were not required for reduction of progeny HIV-1 infectivity. Our results showed that HERV-K Gag CA is important for reduction of HIV-1 release and infectivity but the different regions within CA are involved in the effects on the HIV-1 release and infectivity. Altogether, these findings revealed that HERV-K Gag interferes the HIV-1 replication by two distinct molecular mechanisms.

    See More

External Sources

  1. DOI: 10.1186/s12977-017-0351-8
  2. PMID: 28446240
  3. PMCID: PMC5406883
  4. WOS: 000400703300001

Library Notes

  1. Fiscal Year: FY2016-2017
NCI at FrederickClose Button

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel